Familial defective apolipoprotein B-100 in 12 subjects and their kindred
Geisel J, Schleifenbaum T, Oette K, Weisshaar B (1992)
European Journal of Clinical Chemistry and Clinical Biochemistry 30(11): 729-736.
Zeitschriftenaufsatz
| Veröffentlicht | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Geisel, J.;
Schleifenbaum, T.;
Oette, K.;
Weisshaar, BerndUniBi
Abstract / Bemerkung
Twelve unrelated subjects with heterozygous familial defective apolipoprotein B-100 were identified in a group of 252 patients with type IIa hypercholesterolaemia. Approximately 5% of hypercholesterolaemia can be explained by this mutation in the collective studied. Familial defective apolipoprotein B-100 is therefore the most common known mutation causing primary hypercholesterolaemia. Family studies revealed an additional 14 affected subjects. All family members with the mutation had elevated cholesterol concentrations. In a normolipidaemic control group of 146 subjects the mutation was not present. In the affected individuals a variable expression of total cholesterol concentrations and atherosclerosis was observed. Plasma cholesterol ranged from 6.60 to 14.89 mmol/l with a mean of 9.43 mmol/l. Premature atherosclerosis was present in 4 patients, while one affected woman is now 92 years old and has no symptoms of coronary heart disease or peripheral atherosclerosis. Analysis of the haplotypes and genotypes by 3 biallelic and 1 multi-allelic DNA marker suggests that the disorder is caused in all affected patients by the same rare allele. The fact that the same mutant allele was also identified in other European populations and in a North American population of Caucasian origin argues for a common European origin of this mutation.
Erscheinungsjahr
1992
Zeitschriftentitel
European Journal of Clinical Chemistry and Clinical Biochemistry
Band
30
Ausgabe
11
Seite(n)
729-736
ISSN
0939-4974
Page URI
https://pub.uni-bielefeld.de/record/1868003
Zitieren
Geisel J, Schleifenbaum T, Oette K, Weisshaar B. Familial defective apolipoprotein B-100 in 12 subjects and their kindred. European Journal of Clinical Chemistry and Clinical Biochemistry. 1992;30(11):729-736.
Geisel, J., Schleifenbaum, T., Oette, K., & Weisshaar, B. (1992). Familial defective apolipoprotein B-100 in 12 subjects and their kindred. European Journal of Clinical Chemistry and Clinical Biochemistry, 30(11), 729-736.
Geisel, J., Schleifenbaum, T., Oette, K., and Weisshaar, Bernd. 1992. “Familial defective apolipoprotein B-100 in 12 subjects and their kindred”. European Journal of Clinical Chemistry and Clinical Biochemistry 30 (11): 729-736.
Geisel, J., Schleifenbaum, T., Oette, K., and Weisshaar, B. (1992). Familial defective apolipoprotein B-100 in 12 subjects and their kindred. European Journal of Clinical Chemistry and Clinical Biochemistry 30, 729-736.
Geisel, J., et al., 1992. Familial defective apolipoprotein B-100 in 12 subjects and their kindred. European Journal of Clinical Chemistry and Clinical Biochemistry, 30(11), p 729-736.
J. Geisel, et al., “Familial defective apolipoprotein B-100 in 12 subjects and their kindred”, European Journal of Clinical Chemistry and Clinical Biochemistry, vol. 30, 1992, pp. 729-736.
Geisel, J., Schleifenbaum, T., Oette, K., Weisshaar, B.: Familial defective apolipoprotein B-100 in 12 subjects and their kindred. European Journal of Clinical Chemistry and Clinical Biochemistry. 30, 729-736 (1992).
Geisel, J., Schleifenbaum, T., Oette, K., and Weisshaar, Bernd. “Familial defective apolipoprotein B-100 in 12 subjects and their kindred”. European Journal of Clinical Chemistry and Clinical Biochemistry 30.11 (1992): 729-736.
Daten bereitgestellt von European Bioinformatics Institute (EBI)
4 Zitationen in Europe PMC
Daten bereitgestellt von Europe PubMed Central.
Primary hypercholesterolemia: genetic causes and treatment of five monogenic disorders.
Pullinger CR, Kane JP, Malloy MJ., Expert Rev Cardiovasc Ther 1(1), 2003
PMID: 15030301
Pullinger CR, Kane JP, Malloy MJ., Expert Rev Cardiovasc Ther 1(1), 2003
PMID: 15030301
Mutation analysis of exon 3 of the LDL receptor gene in patients with severe hypercholesterolemia.
Geisel J, Gielen J, Oette K, Herrmann W, Wielckens K., Clin. Chem. Lab. Med. 36(5), 1998
PMID: 9676383
Geisel J, Gielen J, Oette K, Herrmann W, Wielckens K., Clin. Chem. Lab. Med. 36(5), 1998
PMID: 9676383
Familial ligand-defective apolipoprotein B. Identification of a new mutation that decreases LDL receptor binding affinity.
Pullinger CR, Hennessy LK, Chatterton JE, Liu W, Love JA, Mendel CM, Frost PH, Malloy MJ, Schumaker VN, Kane JP., J. Clin. Invest. 95(3), 1995
PMID: 7883971
Pullinger CR, Hennessy LK, Chatterton JE, Liu W, Love JA, Mendel CM, Frost PH, Malloy MJ, Schumaker VN, Kane JP., J. Clin. Invest. 95(3), 1995
PMID: 7883971
Phenotypic expression and frequency of familial defective apolipoprotein B-100 in Belgian hypercholesterolemics.
Kotze MJ, Peeters AV, Langenhoven E, Wauters JG, Van Gaal LF., Atherosclerosis 111(2), 1994
PMID: 7718024
Kotze MJ, Peeters AV, Langenhoven E, Wauters JG, Van Gaal LF., Atherosclerosis 111(2), 1994
PMID: 7718024
References
Daten bereitgestellt von Europe PubMed Central.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Quellen
PMID: 1489844
PubMed | Europe PMC
Suchen in